ArticleNanomaterials (Basel, Switzerland)2019
Facile Fabrication of Flower-Like BiOI/BiOCOOH p-n Heterojunctions for Highly Efficient Visible-Light-Driven Photocatalytic Removal of Harmful Antibiotics.
Article in Nanomaterials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 10 citations in OpenAlex.
- Type II Heterojunction Formed between {010} or {012} Facets Dominated Bismuth Vanadium Oxide and Carbon Nitride to Enhance the Photocatalytic Degradation of Tetracycline.International journal of environmental research and public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
Abstract
Novel heterojunction photocatalysts with remarkable photocatalytic capabilities and durability for degrading recalcitrant contaminants are extremely desired; however, their development still remains quite challenging. In this study, a series of flower-like BiOI/BiOCOOH p-n heterojunctions were fabricated via a controlled in situ anion-exchange process. During the process, BiOI formation and even deposition on BiOCOOH microspheres with tight interfacial contact were realized. As expected, BiOI/BiOCOOH heterojunctions revealed remarkable enhancements in photocatalytic antibiotic degradation capacities under visible light irradiation compared with pristine BiOI and BiOCOOH. The best-performing BiOI/BiOCOOH heterojunction (i.e., IBOCH-2) showed much improved photocatalytic CIP degradation efficiency of approximately 81- and 3.9-fold greater than those of bare BiOI and BiOCOOH, respectively. The eminent photocatalytic performances were due not only to the enhanced capability in harvesting photon energies in visible light regions, but also the accelerated separation of electrons and holes boosted by the p-n heterojunction. Active species trapping tests demonstrated that superoxide free radicals (•O
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.